Challenges and opportunities of 3D-printed drugs from the regulators’ perspective
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Presentation
- By: ZIDAN, Ahmed (CDER Division of Product Quality Research FDA, USA)
Additive manufacturing/3D printing of oral drug products and medical devices has become more attractive to shift the manufacturing strategies to support individualized medicines of the future. The US Food and Drug Administration (FDA) is charged with protecting and promoting the public health by ensuring these products are safe and effective. To.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.